Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

iRadimed Corporation (IRMD) had Revenue of $19.51M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$19.51M
Net Income	$4.69M
Cost of Goods Sold	$4.67M
Gross Profit	$14.84M
Operating Expenses	$14.08M
Operating Income	$5.43M
Non-Operating Income/Expense	$0.51M
Pre-Tax Income	$5.95M
Normalized Pre-Tax Income	$5.95M
Income after Taxes	$4.69M
Income from Continuous Operations	$4.69M
Consolidated Net Income/Loss	$4.69M
Normalized Income after Taxes	$4.69M
EBIT	$5.43M
EBITDA	$5.63M
Weighted-Average Shares Outstanding (Basic)	12.71M
Weighted-Average Shares Outstanding (Diluted)	12.83M
Earnings per Share (EPS) (Basic)	$0.37
Earnings per Share (EPS) (Diluted)	$0.37
Balance Sheet Financials
Current Assets	$75.14M
Property, Plant, and Equipment	$20.38M
Long-Term Assets	$26.59M
Total Assets	$101.73M
Current Liabilities	$8.47M
Long-Term Debt	--
Long-Term Liabilities	$3.20M
Total Liabilities	$11.68M
Common Equity	$90.05M
Tangible Shareholders Equity	$86.80M
Shareholders Equity	$90.05M
Common Shares Outstanding	12.71M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.29M
Cash Flow from Investing Activities	$-3.92M
Cash Flow from Financial Activities	$-2.28M
Beginning Cash	$52.23M
End Cash	$50.33M
Increase/Decrease in Cash	$-1.90M
Stock-Based Compensation	$0.83M
Common Stock Dividends Paid	$-2.16M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	8.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	76.08%
Operating Margin	27.84%
EBIT Margin	27.84%
EBITDA Margin	--
Pre-Tax Profit Margin	30.47%
Profit Margin	24.02%
Free Cash Flow	$0.37M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.19
Inventory Turnover	0.44
Receiveable Turnover	1.54
Days Sales in Receivables	58.61
Return on Equity	5.21%
Return on Tangible Equity	5.40%
Return on Assets	4.61%
Return on Investments	5.21%
Book Value Per Share	$7.08
Free Cash Flow per Share	$0.03
Operating Cash Flow per Share	$0.33

Data from Zacks Investment Research, Inc.